Are PBLS insiders buying or selling?

No PBLS insiders reported open-market purchases or sales in the last 90 days.

When was the last PBLS insider purchase?

No open-market insider purchase of Parabilis Medicines, Inc. stock was reported in the last 90 days.

Where does PBLS insider trading data come from?

Watch Insiders reads the SEC Form 4 filings that Parabilis Medicines, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.

PBLSSector not reported

Parabilis Medicines, Inc. (PBLS) Insider Trading

In the last 90 days, no Parabilis Medicines, Inc. (PBLS) insiders reported open-market purchases or sales on SEC Form 4.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers: 0
90-day purchase value: $0.00
Corporate buyers: 0
Latest transaction: Jul 22, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
Date	Insider name	Role	Type	Shares	Price	Total value
Jul 22, 2026	RA Capital Healthcare Fund LP	Corporate insider	Open Market Purchase	244,593	$28.29	$6,919,560
Jul 22, 2026	Ra Capital Management L.P.	Director / 10% Owner	Open Market Purchase	244,593	$28.29	$6,919,560
Jul 22, 2026	Peter Kolchinsky	Corporate insider	Open Market Purchase	244,593	$28.29	$6,919,560
Jul 22, 2026	Rajeev M. Shah	Corporate insider	Open Market Purchase	244,593	$28.29	$6,919,560
Jul 22, 2026	RA Capital Nexus Fund III L.P.	Corporate insider	Open Market Purchase	244,593	$28.29	$6,919,560
Jun 15, 2026	Alan Sebulsky	Director	Open Market Purchase	17,500	$27.06	$473,529
Jun 11, 2026	RA Capital Healthcare Fund LP	Corporate insider	Open Market Purchase	21,188,750	$20.00	$423,775,000
Jun 11, 2026	Ra Capital Management L.P.	Director / 10% Owner	Open Market Purchase	21,188,750	$20.00	$423,775,000
Jun 11, 2026	Peter Kolchinsky	Corporate insider	Open Market Purchase	21,188,750	$20.00	$423,775,000
Jun 11, 2026	Rajeev M. Shah	Corporate insider	Open Market Purchase	21,188,750	$20.00	$423,775,000
[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]
[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]

🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

PBLS insider trading FAQ

Are PBLS insiders buying or selling?: No PBLS insiders reported open-market purchases or sales in the last 90 days.
When was the last PBLS insider purchase?: No open-market insider purchase of Parabilis Medicines, Inc. stock was reported in the last 90 days.
Where does PBLS insider trading data come from?: Watch Insiders reads the SEC Form 4 filings that Parabilis Medicines, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.